Key result
Diabetes is linked to ~24% lower odds of post-ACS smoking cessation, attenuated after full adjustment.
Why the study?
People with diabetes smoke at rates similar to those without diabetes, carrying cardiovascular consequences, prompting a comparison of smoking cessation rates between groups 1 year after an acute coronary syndrome.
Does diabetes mellitus reduce 1-year smoking cessation rates in patients who smoke hospitalized for acute coronary syndrome?
Cohort (n=2,457)
Yes
Does diabetes mellitus reduce 1-year smoking cessation rates in patients who smoke hospitalized for acute coronary syndrome?
Smokers with diabetes have significantly lower 1-year smoking cessation rates after an acute coronary syndrome compared to those without diabetes, largely driven by lower cardiac rehabilitation attendance and higher baseline cardiovascular comorbidity.
Answers are grounded in this paper and cite their sources.
Smokers with diabetes post-ACS may need targeted cessation support; leaves open independent diabetes effect after adjustment for rehabilitation and comorbidity.
INTRODUCTION: People with diabetes smoke at similar rates as those without diabetes, with cardiovascular consequences. Smoking cessation rates were compared between people with and without diabetes 1 year after an acute coronary syndrome (ACS). AIMS AND METHODS: People with ACS who smoked and were part of an observational prospective multicenter study in Switzerland were included from 2007 to 2017 and followed for 12 months. Seven-day point prevalence abstinence was assessed at 12 months follow-up. Association between diabetes and smoking cessation was assessed using multivariable-adjusted logistical regression model. RESULTS: 2457 people with ACS who smoked were included, the mean age of 57 years old, 81.9% were men and 13.3% had diabetes. At 1 year, smoking cessation was 35.1% for people with diabetes and 42.6% for people without diabetes (P-value .01). After adjustment for age, sex, and educational level, people with diabetes who smoked were less likely to quit smoking compared with people without diabetes who smoked (odds ratio [OR] 0.76, 95% confidence interval [CI] 0.59-0.98, P-value = .037). The multivariable-adjusted model, with further adjustments for personal history of previous cardiovascular disease and cardiac rehabilitation attendance, attenuated this association (OR 0.85, 95% CI 0.65-1.12, P-value = .255). Among people with diabetes, cardiac rehabilitation attendance was a positive predictor of smoking cessation, and personal history of cardiovascular disease was a negative predictor of smoking cessation. CONCLUSIONS: People with diabetes who smoke are less likely to quit smoking after an ACS and need tailored secondary prevention programs. In this population, cardiac rehabilitation is associated with increased smoking cessation. IMPLICATIONS: This study provides new information on smoking cessation following ACSs comparing people with and without diabetes. After an ACS, people with diabetes who smoked were less likely to quit smoking than people without diabetes. Our findings highlight the importance of tailoring secondary prevention to people with diabetes.
No takes yet. Share an insight, caveat, or question.
Clement et al. (2022) conducted a cohort in Acute coronary syndrome in active smokers (n=2,457). Diabetes mellitus vs. No diabetes mellitus was evaluated on Seven-day point prevalence smoking abstinence at 12 months (OR 0.76, 95% CI 0.59-0.98, p=0.037). Diabetes was associated with lower 1-year smoking cessation after ACS, attenuated after full clinical adjustment.
Synapse has enriched 10 related papers. Consider them for comparative context: